tm logo
BIOZOL TRANSDERMAL SERUM
Live/Registered
REGISTERED

on 13 Oct 2020

Last Applicant/ Owned by

1001 Avenida Pico, Suite C-501

San Clemente

CA

92673

Serial Number

87316486 filed on 27th Jan 2017

Registration Number

6175489 registered on 13th Oct 2020

in the Principal Register

Correspondent Address

Sean B. MacKenzie

Sean B. MacKenzie

SAN CLEMENTE CA 92672

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

BIOZOL TRANSDERMAL SERUM

Pharmaceutical formulation for transcutaneous drug delivery for the treatment of acne, fungal infections, gout, diaper rash, skin infections, shingles, dandruff, eczema, psoriasis, seborrheic dermatitis, arthritis, joint inflammation, pain, fever blisters, cold sores, insect bites, stings, poison ivy, poison oak, and poison sumac

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical formulation for transcutaneous drug delivery for the treatment of acne, fungal infections, gout, diaper rash, skin infections, shingles, dandruff, eczema, psoriasis, seborrheic dermatitis, arthritis, joint inflammation, pain, fever blisters, cold sores, insect bites, stings, poison ivy, poison oak, and poison sumac


First Use Date in General

18th Aug 2020

First Use Date in Commerce

18th Aug 2020

Mark Details


Serial Number

No 87316486

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
13th Oct 2020REGISTERED-PRINCIPAL REGISTER
11th Sep 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10th Sep 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
24th Aug 2020STATEMENT OF USE PROCESSING COMPLETE
18th Aug 2020USE AMENDMENT FILED
18th Aug 2020TEAS STATEMENT OF USE RECEIVED
08th Jan 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07th Jan 2020EXTENSION 5 GRANTED
12th Dec 2019EXTENSION 5 FILED
12th Dec 2019TEAS EXTENSION RECEIVED